Drug resistance biomarker could improve cancer treatment
Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that cause drug resistance. A key gene that determines resistance to a range of cancer drugs has been reported in a study published ...
Cancer
Nov 21, 2012 |
not rated yet |
0
|
'Different kind of stem cell' possesses attributes favoring regenerative medicine
A research team at Georgetown Lombardi Comprehensive Cancer Center say the new and powerful cells they first created in the laboratory a year ago constitute a new stem-like state of adult epithelial cells. They say these ...
Medical research
Nov 19, 2012 |
5 / 5 (1) |
0
|
Study shows bone metastases treatment can improve overall survival
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent ...
Cancer
Nov 15, 2012 |
not rated yet |
0
Stem cell finding could advance immunotherapy for lung cancer
A University of Cincinnati (UC) Cancer Institute lung cancer research team reports that lung cancer stem cells can be isolated—and then grown—in a preclinical model, offering a new avenue for investigating immunotherapy ...
Cancer
Nov 13, 2012 |
4.5 / 5 (2) |
0
|
'Lung-on-a-chip' sets stage for next wave of research to replace animal testing
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have mimicked pulmonary edema in a microchip lined by living human cells, as reported today in the journal Science Tr ...
Medical research
Nov 07, 2012 |
5 / 5 (3) |
0
|
New drug target found for cystic fibrosis lung disease
Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation. The finding offers a potential ...
Inflammatory disorders
Nov 07, 2012 |
5 / 5 (1) |
0
New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
A newly developed antibody targeting a signalling pathway that is frequently active in solid tumours has shown encouraging signs of efficacy in its first trial in humans, researchers will report at the 24th EORTC-NCI-AACR ...
Cancer
Nov 06, 2012 |
5 / 5 (2) |
0
Molecular lung cancer test identifies patients at high risk of death even after surgery
(Medical Xpress)—One of the toughest issues facing patients who have surgery for very early-stage lung cancer is uncertainty: Despite complete removal of their small lung tumors and no evidence of metastasis, ...
Cancer
Nov 02, 2012 |
not rated yet |
0
|
Scientists identify new target for lung cancer treatment
A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed ...
Cancer
Nov 01, 2012 |
4 / 5 (1) |
0
|
Microscopic packets of stem cell factors could be key to preventing lung disease in babies
Researchers at Boston Children's Hospital have found that microscopic particles containing proteins and nucleic acids called exosomes could potentially protect the fragile lungs of premature babies from serious lung diseases ...
Medical research
Oct 31, 2012 |
not rated yet |
0
|
Research findings breathe new life into lung disease
It turns out the muscle cells on the outside of blood vessels have been wrongly accused for instigating lung disease. New research shows that while these muscle cells are responsible for constricting or dilating the blood ...
Medical research
Oct 24, 2012 |
not rated yet |
0
|
Lung mucus gel scaffold prevents nanoparticles from getting through
Mucus coats our airways' internal surfaces. The viscous gel humidifies the lungs and prevents viruses and other small particles like diesel soot from entering the body unchecked. Previously unclear was the ...
Medical research
Oct 23, 2012 |
5 / 5 (2) |
0
|
Chinese herbs show promise for lung cancer, flu, and idiopathic pulmonary fibrosis
Chinese herbs, including JHQG, BFXL, and BFHX, may show significant benefits for patients with non-small cell lung cancer (NSCLC), idiopathic pulmonary fibrosis (IPF), and influenza.
Medications
Oct 22, 2012 |
not rated yet |
0
Statins may help prolong survival in NSCLC resection
Patients who have undergone resection for non-small cell lung cancer (NSCLC) may improve their overall survival and reduce the risk of recurrence by taking statins.
Cancer
Oct 22, 2012 |
not rated yet |
0
Painless skin rash predicts survival benefit from latest lung cancer drug, study finds
(Medical Xpress)—Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, c ...
Cancer
Oct 17, 2012 |
not rated yet |
0
